Akkermansia GLP-1 Probiotics Compared 2026: Everyone Who Prints a Number Is Under the Trial Dose
Our best-of page told readers to run four checks against the Akkermansia products we hadn't reviewed. We went and ran them ourselves. The results complicate our own ranking, so we are publishing them plainly — including a competitor selling a near-identical formula to our top pick for a third of the price.
By Med Consumer Watch Team
When we published our best GLP-1 probiotic ranking, we named several products we had not reviewed in depth and told readers to apply four checks to them themselves. That was an open loop, and leaving it open was unsatisfactory.
So we ran the checks. This is what we found across Codeage, Designs for Health and California Gold Nutrition, checked on August 3, 2026.
We have no affiliate relationship with any of the three. We do have one with CoreAge Rx, whose product currently holds our top spot — which is exactly why the finding below is published rather than quietly filed.
The headline is uncomfortable and applies to the whole field, including our own top pick.
The human trial everyone in this category cites — Depommier and colleagues in Nature Medicine, 2019 — used 10^10 bacteria per day, that is 10 billion. Every brand we found that actually prints a number is between 100 million and 1 billion. That is between one-tenth and one-hundredth of the studied dose.
And the brands that do not print a number cannot be checked at all.
The Numbers, Side by Side
Here is the field as it stands, with the trial dose at the top for reference.
Product | Disclosed count | Price per serving
Depommier 2019 trial dose | 10,000 million (10^10) | not a product
California Gold Nutrition Akkermansia + Probiotics GLP-1 Complex | 1,000 million AFU/TFU | ~$0.38
Read that top line against everything below it. If the 2019 trial is the reason you are buying Akkermansia — and for most people it is, because it is essentially the only human metabolic trial in the category — then a product at 500 million cells is delivering one twentieth of what produced those results. Nobody in this category advertises that comparison, and we have not found a dose-response study establishing that a twentieth of the dose does a twentieth, or any, of the job.
That trial's own results are worth remembering too, because they are frequently retold badly. In the pasteurized arm, insulin sensitivity improved 28.6% (p=0.002), insulinaemia fell 34.1% (p=0.006) and total cholesterol fell 8.7% (p=0.02). Body weight fell 2.27 kg — and that result did NOT reach statistical significance (p=0.091). It was a proof-of-concept pilot with 32 completers.
A Correction to Our Own Ranking
We rated CoreAge Rx GLP-1 Support our #1 supplement, at 8.4, partly on the coherence of its formula: three probiotic species paired with the prebiotic substrate they ferment.
Running these checks turned up something we should have caught, and it cuts against that reasoning.
Codeage GLP-1 Probiotic+ contains the same three species plus chicory inulin.Akkermansia muciniphila, Clostridium butyricum, Bifidobacterium infantis, with chicory inulin as the prebiotic. CoreAge Rx adds potato resistant starch as a second prebiotic and uses a delayed-release capsule; otherwise the concept is the same one.
That matters in two directions:
First, the formula is not distinctive. We credited CoreAge Rx for a "mechanistically coherent" combination, and it is — but it is a combination at least one competitor arrived at independently, and that is worth knowing before paying a premium for it. This is the second time in this series we have found a supposedly proprietary formula shared across brands, after the Sukré–TriBiome–Akkermansia kit that Bioma and Inno Supps both ship at identical doses.
Second, Codeage prints its count and CoreAge Rx does not. Codeage says 500 million AFU. That number is low against the trial. But it is a number, and a shopper can act on it. CoreAge Rx's landing page shows no count at all, which means it could be higher or lower and you have no way to find out.
And the price gap is large. Codeage's 90-serving bottle is $29.99 — about 33 cents a serving. CoreAge Rx runs 79 cents to $1.97. For a near-identical species combination, that is roughly two to six times the price.
We are not withdrawing the CoreAge Rx recommendation, and we want to be explicit about why rather than leave you guessing. It still holds real advantages nothing here matches: a delayed-release capsule engineered to survive gastric acid, cold-chain shipping with refrigerate-after-opening guidance, published third-party testing at manufacture and before release, and the clearest contraindications section in the category — including telling immunocompromised readers to stay away and stating plainly that it is not a prescription GLP-1. Those are real and they are worth paying something for. But "something" is not unlimited, and if disclosed potency is what you care about most, Codeage and California Gold Nutrition currently give you more to check for less money.
California Gold Nutrition: The Cheapest Disclosure
Akkermansia + Probiotics GLP-1 Complex, 60 veggie capsules, around $22.50 — roughly 38 cents a serving, the cheapest per-serving Akkermansia product we found.
What it discloses, and this is genuinely good practice:
"4 live and active strains plus 1 pasteurized strain." That single sentence answers a question almost nobody else in this category answers — which organisms are alive and which are not. It matters, because in the 2019 trial the pasteurized arm produced the metabolic results, so a pasteurized preparation is a legitimate design choice rather than a shortcut, and dosing pasteurized organisms by mass is defensible in a way that dosing live ones by mass is not.
Potency in AFU/TFU, listed around 1 billion — active fluorescent units, an appropriate viable-cell measure rather than milligrams. It also carries hyaluronic acid.
Where it falls short: 1 billion is still a tenth of the trial dose. And being an iHerb house brand, it competes on price, which generally means less investment in delivery technology — we found no delayed-release or cold-chain claim.
Who it suits: someone who wants to try Akkermansia cheaply, understands the dose is well below the studied one, and values knowing what they are actually taking over paying for delivery engineering.
If you are shopping this category on price, this is the honest budget answer, and at 38 cents a serving the cost of being wrong is small. Just do not expect it to reproduce a trial that used ten times the dose.
Designs for Health: The Practitioner Option
Akkermansia Pro GLP-1 Probiotic, launched June 17, 2026 through the practitioner channel.
This is the most technically ambitious formula in the group, and two things stand out.
It pairs live Akkermansia muciniphila with BPL1®, a patented, heat-treated postbiotic. BPL1 is not a marketing name attached to nothing — it is a clinically studied ingredient with published human data on body composition and abdominal fat, and pairing a live keystone strain with a characterised postbiotic is a more sophisticated design than most of this shelf attempts.
"Powered by patented oxygen-free technology", described as preserving oxygen-sensitive strains for stability and delivery. That is a direct engineering answer to the central manufacturing problem with Akkermansia — it is a strict anaerobe, and oxygen kills it. It is a different solution to the same problem CoreAge Rx addresses with a delayed-release capsule and cold shipping, and it is a real one.
Designs for Health is a practitioner-channel brand with a named Chief Medical Officer, which puts it in a different category from the direct-to-consumer products dominating this space.
What we could not verify: the launch materials do not publish a CFU or AFU count, and pricing is practitioner-channel rather than openly listed. So it fails our first check on the public information available — not because the number is bad, but because we could not find it.
A note on how to read "clinically studied" across all of these brands, including this one. BPL1 has real published data, and Designs for Health describes it accurately. But the studies are on the INGREDIENT, at the dose used in those studies — not on the finished product at whatever dose it contains. That distinction has been the single most common failure across our whole review series, and it applies to the good brands as much as the bad ones. Ask what dose the product contains, and whether it matches the study.
Codeage: A Whole GLP-1 Product Line
Codeage has built out an entire GLP-1 range, which is worth walking through because it shows how quickly this category is being filled in.
GLP-1 Probiotic+ | $24.99 / 30 servings | 500 million AFU — A. muciniphila, C. butyricum, B. infantis, chicory inulin
GLP-1 Probiotic+ Large | $29.99 / 90 servings | Same formula, about 33 cents a serving
GLP-Advantage+ | $39.99 | Berberine HCl, chromium, green tea (50% EGCG), gymnema, curcumin, taurine, resveratrol, boron, plus 100 million AFU Akkermansia and B. infantis
The other products in the range are a different proposition and we would treat them more sceptically. GLP-Advantage+ drops the Akkermansia to 100 million AFU and fills the capsule with berberine and botanicals — and berberine at an undisclosed dose is a CYP3A4 and P-glycoprotein inhibitor that can raise levels of other medications you take. GLP-Harmony Companion+ combines lion's mane, PEA, colostrum, shilajit, elder, blueberry, citrus bioflavonoids, broccoli seed, Akkermansia and resveratrol in one capsule; ten-plus botanicals in a single capsule is an ingredient list, not a dose. Colostrum also means dairy, which matters if you are lactose-intolerant — and slowed gastric emptying on a GLP-1 tends to make that worse.
The Probiotic+ Large at 33 cents a serving is the best value we found in this entire category — a disclosed 500 million AFU of three named species with chicory inulin, one capsule daily, cGMP-manufactured, vegan. It is the same species combination as our top pick at a fraction of the price. Its weakness is the same as everyone else's: the dose is a twentieth of the trial's.
So What Should You Actually Do?
Four honest conclusions from running our own checks against our own ranking.
1. Decide what you are buying before you compare prices. If you want disclosed potency, Codeage and California Gold Nutrition publish counts and cost 33–38 cents a serving. If you want delivery engineering — surviving stomach acid, cold chain, refrigeration — CoreAge Rx and Designs for Health have built for it and charge for it. Nobody currently offers both at the low price.
2. Calibrate your expectations to the dose, not the marketing. Every disclosed product is at a tenth or less of the trial dose. Nobody has shown that a tenth works. Treat this as a plausible, cheap, low-risk experiment in gut health rather than a metabolic intervention.
3. Judge it on digestion, not the scale. The best-evidenced outcomes anywhere near this category are bowel-symptom endpoints — the published resistant potato starch trial improved stool consistency and reduced diarrhoea- and constipation-associated bowel movements. Even the Akkermansia trial's weight result was not statistically significant.
4. And keep the priorities straight. On a GLP-1, protein at 20–30 g per meal plus resistance training does far more for your outcome than any probiotic in this comparison. Our guide to what to take alongside GLP-1 medication sets out the full order.
One safety point that applies to every product on this page. Live probiotics are not appropriate if you are severely immunocompromised, on immunosuppressive therapy, recovering from IV antibiotics, or have an active C. difficile infection — probiotic-associated bacteraemia and fungaemia are documented in vulnerable patients. Of the brands here, only CoreAge Rx states this on its own page. That it took a review site to say it for the others is itself a finding.
Frequently Asked Questions
What is the right Akkermansia dose?
The only human metabolic trial used 10^10 — 10 billion — bacteria daily for three months. Every retail product we found that publishes a count is between 100 million and 1 billion, so a tenth to a hundredth of that. No dose-response study establishes that the lower amounts work.
Which Akkermansia supplement is cheapest?
California Gold Nutrition's GLP-1 Complex at roughly $0.38 a serving and Codeage's GLP-1 Probiotic+ Large at about $0.33 a serving are the cheapest we found that disclose a count.
Is pasteurized Akkermansia worse than live?
No — and this surprises people. In the 2019 trial the pasteurized arm produced the metabolic results. Pasteurized preparations are also more stable and can legitimately be dosed by mass. A brand using pasteurized organisms and saying so is being straightforward, not cutting corners.
Is Codeage the same as CoreAge Rx GLP-1 Support?
Not identical, but close in concept: both combine Akkermansia muciniphila, Clostridium butyricum and Bifidobacterium infantis with chicory inulin. CoreAge Rx adds potato resistant starch and a delayed-release capsule with cold-chain shipping; Codeage publishes an AFU count and costs considerably less.
Why does delayed-release matter?
Gastric acid sits around pH 1.5–3.5 and kills microorganisms efficiently. A capsule designed to survive the stomach delivers more viable organisms to the colon, which is the only place they can colonise.
What is BPL1?
A patented, heat-treated postbiotic with published human data on body composition and abdominal fat, used in Designs for Health's formula alongside live Akkermansia.
Does any of this cause weight loss?
No product here has a trial showing it does. The trial these products are built on measured a 2.27 kg weight difference that did not reach statistical significance, alongside metabolic markers that did improve significantly.
Who should not take these?
Anyone severely immunocompromised, on immunosuppressive therapy, recovering from IV antibiotics, with active C. difficile, or pregnant or breastfeeding without clinician advice.
The Bottom Line
Our ratings: Codeage GLP-1 Probiotic+ 6.6 / 10 · California Gold Nutrition GLP-1 Complex 6.5 / 10 · Designs for Health Akkermansia Pro GLP-1 7.0 / 10.
We told readers to run four checks against the Akkermansia products we had not reviewed. Running them ourselves produced a finding that complicates our own ranking, so here it is plainly.
Every product in this category that prints a number is far below the dose that generated the evidence. The 2019 Nature Medicine trial used 10 billion bacteria daily. California Gold Nutrition publishes 1 billion. Codeage publishes 500 million in its main probiotic and 100 million in GLP-Advantage+. That is a tenth to a hundredth, with no dose-response data showing the lower amounts do anything. The brands that publish no count at all — including our own top pick, CoreAge Rx — cannot be checked either way.
And the formula we praised is not unique. Codeage's GLP-1 Probiotic+ pairs the same three species with chicory inulin, discloses 500 million AFU, and sells at 33 cents a serving against CoreAge Rx's 79 cents to $1.97. That is the second time in this series a supposedly distinctive formula has turned out to be shared, after Bioma and Inno Supps shipped identical Sukré, triacetin and Akkermansia doses.
CoreAge Rx keeps our recommendation because delayed-release delivery, cold-chain handling, published third-party testing and a genuine contraindications section are real advantages that nothing here matches — and because it tells buyers plainly it is not a prescription GLP-1. But if disclosed potency per dollar is what you care about, Codeage and California Gold Nutrition currently give you more for less, and you should know that from us rather than from a comparison table written by someone selling you something.
Designs for Health scores highest of the three on design — live Akkermansia paired with the clinically studied BPL1 postbiotic, delivered by patented oxygen-free technology — and lowest on transparency, because we could not find a published count.
Buy any of these as a cheap experiment in gut health. None of them is a metabolic intervention, and the trial they all point at did not find a significant weight effect.
Akkermansia muciniphila as a strict anaerobe with oxygen and heat sensitivity, and the resulting manufacturing and stability constraints on live preparations
Gastric pH of approximately 1.5–3.5 and its bactericidal effect on orally administered probiotics — the rationale for delayed-release and enteric delivery
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.
One winner gets a 12-month CoreAge Rx tirzepatide subscription — a $1,788 value ($149/mo for 12 months). No purchase necessary. Entries close September 30, 2026.
CoreAge Rx dispenses compounded tirzepatide. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness, or manufacturing quality before they reach you, and a compounded preparation is not a generic equivalent of an FDA-approved drug.
